Skip to main content

Table 5 Ongoing phase I or II trials in osteosarcoma (Assessed from www.ClinicalTrials.gov)

From: Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment

ClinicalTrials.gov Identifier

Sponsors

Title

Status

NCT00102531

Transave

Phase Ib/IIa non-randomised study of SLIT Cisplatin by inhalation in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung

Recruiting

NCT01002092

Shandong Simcere-Medgenn

Bio-pharmaceutical Co., Ltd

A randomized, controlled multicenter trial of Endostar combined with chemotherapy for treatment of osteosarcoma (phase II)

Recruiting

NCT00889057

Italian Sarcoma Group

Phase II, open label, non-randomized study of second or third line treatment with Sorafenib (BAY 43-9006) in patients affected by relapsed high-grade osteosarcoma

Recruiting

NCT00752206

NCT00923286

Sarcoma Alliance for Research through Collaboration (SARC)

A randomized, double-blinded, placebo-controlled, multi-institutional, phase II study of AZD0530, a selective Src kinase inhibitor, in patients with recurrent osteosarcoma localized to the lung

Recruiting

NCT01005043

University of Heidelberg

Phase I/II therapy non-randomised trial to determine the safety and efficacy of heavy ion radiotherapy in patients with osteosarcoma

Not yet recruiting

NCT00902044

Baylor College of Medicine

Administration of Her2 Chimeric antigen receptor expressing T Cells for subjects with advanced osteosarcoma (HEROS) (phase I)

Not yet recruiting